1.
Antioxid. calid. vida
;
6(23): 6-14, mayo 1999. ilus
Article
in Spanish
| LILACS
| ID: lil-241863
Subject(s)
Humans , Hypolipidemic Agents/therapeutic use , Arteriosclerosis/physiopathology , Cholesterol, LDL/drug effects , Coronary Disease/drug therapy , Coronary Vessels/drug effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Triglycerides/adverse effects , Anticholesteremic Agents/pharmacology , Anticholesteremic Agents/therapeutic use , Hypolipidemic Agents/pharmacology , Angioplasty, Balloon, Coronary/adverse effects , Antioxidants , Apolipoproteins A/adverse effects , Apolipoproteins B/adverse effects , Arteriosclerosis/drug therapy , Atherosclerosis/drug therapy , Atherosclerosis/physiopathology , Cerebrovascular Disorders/epidemiology , Cerebrovascular Disorders/mortality , Cholesterol, HDL/adverse effects , Cholesterol, LDL/blood , Cholestyramine Resin/therapeutic use , Clofibrate/pharmacology , Clofibrate/therapeutic use , Coronary Disease/physiopathology , Coronary Disease/prevention & control , Coronary Vessels/pathology , Double-Blind Method , Gemfibrozil/pharmacology , Gemfibrozil/therapeutic use , Longitudinal Studies , Lovastatin/therapeutic use , Meta-Analysis , Microbodies/drug effects , Myocardial Infarction/physiopathology , Pravastatin/therapeutic use , Probucol/adverse effects , Probucol/therapeutic use , Prospective Studies , Risk , Risk Factors , Simvastatin/therapeutic use , Treatment Outcome , Triglycerides/blood
2.
In. Casasbuenas, Jaime; Chalem, Fernando, ed. Compendio de terapeutica. s.l, Acta Medica Colombiana, jul. 1988. p.226-9, tab.
Monography
in Spanish
| LILACS
| ID: lil-117107
Subject(s)
Humans , Male , Female , Hypolipoproteinemias/drug therapy , Nicotinic Acids/administration & dosage , Nicotinic Acids/pharmacokinetics , Nicotinic Acids/therapeutic use , Bezafibrate/adverse effects , Bezafibrate/pharmacokinetics , Cholestyramine Resin/administration & dosage , Cholestyramine Resin/adverse effects , Cholestyramine Resin/therapeutic use , Clofibrate/adverse effects , Clofibrate/pharmacokinetics , Clofibrate/therapeutic use , Colestipol/administration & dosage , Colestipol/adverse effects , Colestipol/therapeutic use , Neomycin/administration & dosage , Neomycin/therapeutic use , Probucol/administration & dosage , Probucol/adverse effects , Probucol/pharmacokinetics
3.
Arq. bras. cardiol
;
46(2): 77-80, fev. 1986. ilus
Article
in Portuguese
| LILACS
| ID: lil-34900